Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 and Leucovorin in Gemcitabine-Refractory Advanced Pancreatic Cancer
NCT01074996Phase 2Unknown
- Sponsor
- 307 Hospital of the People's Liberation Army
- Start
- Feb 2010
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of folinic acid in pancreatic cancer (PC), sponsored by 307 Hospital of the People's Liberation Army. Status: unknown.
02
Drugs
folinic acid
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01074996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01074996.